John Kellum, MD to Become CMO of Spectral Medical
Professor and Vice Chair for Research John Kellum, MD announced he is taking a two-year leave of absence to join Spectral Medical, a biotech company, as Chief Medical Officer. Dr. Kellum will retain his faculty appointment at the University of Pittsburgh School of Medicine and continue to attend at UPMC Magee-Women’s Hospital. His leave of absence will be effective March 1, 2021.
“John is one of the world’s foremost experts in critical care nephrology,” said Derek Angus, MD, MPH, who is the Mitchell P. Fink Chair of the Department of Critical Care Medicine. “We wish him success in his new role at Spectral Medical.”
Dr. Kellum began his professional career when he joined the Department of Anesthesiology 1992 after completing a fellowship in Critical Care Medicine. Widely known and admired for his scientific productivity and innovation, he is one of the most highly cited critical care researchers in the world (one of only five critical care physicians on the Clarivate web of science ‘highly cited researchers’ list). He is a founding member of the Acute Dialysis Quality Initiative, a group of international experts who developed the first widely accepted consensus definition for acute renal failure.
As a faculty member in the Department of Critical Care Medicine, he has been continuously funded by the NIH since 2001, and in 2013 he established the department’s Center for Critical Nephrology. Dr. Kellum holds the Endowed Chair in Critical Care Research and as Vice Chair of Research has led the department’s research enterprise for the past 12 years. In that role, he oversaw enormous growth in research activity and optimized the operations of the Office of Research.